Skip to main content
Figure 3 | BMC Gastroenterology

Figure 3

From: Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy

Figure 3

Comparative survival analyses between patients with greater PET-CT response, lesser PET-CT response and early progression. A: Overall survival (OS); B: Progression-free Survival (PFS); C: Local Regional Progression-free Survival (LRPFS). Solid line: greater response; Doted line: lesser response; Dashed line: early progression.

Back to article page